bmy price target

Other analysts have also issued research reports about the stock. In that case, then, we find that the current price level is +32.73% off the targeted high while a plunge would see the stock lose -3.19% from current levels. It offers products in hematology, oncology, cardiovascular, and immunology therapeutic classes. That equals the target price of $67.34, or 16.7% more than today’s (Sept. 21) price of $57.77. 1 Wall Street analysts have issued ratings and price targets for Bloomsbury Publishing plc (BMY.L) in the last 12 months. Bristol Myers Squibb Co. analyst estimates, including BMY earnings per share estimates and analyst recommendations. Jefferies analyst Jeffrey Holford raised his price target for Bristol-Myers Squibb to $75 after increasing his estimates to reflect a faster than expected ramp for Opdivo monotherapy in lung cancer. Eat Beyond is a rising new star in the alternative meat space and is the very first to provide retail investors with the opportunity to participate in one of the fastest growing industries around! MarketBeat does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security. Bristol-Myers Analyst Says 'Big 7' Pipeline Assets Hold $15B In Peak Sales Potential (Analyst Color, Biotech, BLUE, BMY, INCY, Price Target, Reiteration, Analyst Ratings, Trading Ideas / Wed, 10:45am) The Average True Range (ATR) for Bristol-Myers Squibb Company is set at 1.38, with the Price to Sales ratio for BMY stock in the period of the last 12 months amounting to 3.46. Bristol-Myers Squibb Company was founded in 1887 and is headquartered in New York, New York. Analyst Ratings Network (ARN) provides comprehensive coverage of stock ratings, including equities research analysts’ upgrades, downgrades, new coverage and price target 17. Start Your Risk-Free Trial Subscription Here, Here’s Where to Lock Profits on Stratasys (NASDAQ: SSYS) Stock, Cal-Maine (NASDAQ:CALM) Foods Spikes On Results And Outlook, Time to Trim Profits on Celsius Holdings (NASDAQ: CELH) Stock, 3 Stocks to Consider Buying with Your Stimulus Check, Big Year for Banks as Bank of America Securities Upgrades JPMorgan Chase (NYSE:JPM), Citi Expects Big Things From NVIDIA (NASDAQ:NVDA) at CES 2021, Bed, Bath & Beyond (NASDAQ:BBBY) Hits a Wall, Conagra Brands Is A Good Bet For Dividends And Growth, Watch For An Entry Point In Zillow (NASDAQ: ZG), Mastercard (NYSE: MA) Steadies For The Next Stage Of The Rally, 7 Stocks to Buy As Americans Receive Stimulus Checks, 7 Outdoor Recreation Stocks For Growth And Dividends, 8 EV Stocks To Electrify Your Growth Portfolio, 7 Cloud Computing Stocks to Lift Your Portfolio to New Heights, 7 Infrastructure Stocks That May Help Rebuild America, 7 Food Stocks That Are Leading Through Innovation, 7 Entertainment Stocks That Are Still Delighting Investors, 7 Clean Energy Stocks With A Bright Future, Receive Analysts' Upgrades and Downgrades Daily. BMY stock is worth $67.34 per share. View our full suite of financial calendars and market data tables, all for free. Sell near 61.00-61.70 zone with stops above 62.45 for initial target below 57 level. Rating by ">Cory Kasimov at JPMorgan Chase & Co. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data. The average price target represents a 19.60% upside from the last price of $62.03. In addition, it offers Reyataz, a protease inhibitor to treat human immunodeficiency virus (HIV); Sustiva franchise, a non-nucleoside reverse transcriptase inhibitor for the treatment of HIV; and Daklinza NS5A replication complex inhibitor, Sunvepra NS3 protease inhibitor, and Beclabuvir NS5B inhibitor. Already a subscriber? Get the latest Zacks research report on BMY — FREE. Give thumbs up if you really like the trade idea. The brokerage currently has an overweight rating on the biopharmaceutical company’s stock. According to 11 Wall Street analysts that have issued a 1 year BMY price target, the average BMY price target is $72.82, with the highest BMY stock price forecast at $80.00 and the lowest BMY stock price forecast at $65.00. It also provides Sprycel, a tyrosine kinase inhibitor for the treatment of Philadelphia chromosome-positive chronic myeloid leukemia; Yervoy, a monoclonal antibody for the treatment of patients with unresectable or metastatic melanoma; Empliciti, a humanized monoclonal antibody for the treatment of multiple myeloma; and Baraclude, an oral antiviral agent for the treatment of chronic hepatitis B. Move your mouse over past months for details. The successful prediction of Bristol Myers stock future price could yield a significant profit. Overall (Y) wave will end at around 54 or lower level. The average price target represents a 21.07% increase from the last price of $61.42. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Bristol-Myers Squibb Company (NYSE:BMY)’s beta value is holding at 0.65, while the average true range (ATR) indicator is presently reading 1.49. Raymond James currently has an outperform rating on the biopharmaceutical company’s stock. Should I buy Bristol Myers Squibb Company (BMY)? The average price target is $120.44 with a high forecast of $126.00 and a low forecast of $113.00.The average price target represents a 10.00% increase from the last price of $109.49. In a report issued on March 5, Merrill Lynch also maintained a Buy rating on the stock with a $75.00 price target. Posted by Joseph McCarthy on Sep 25th, 2020 Bristol-Myers Squibb (NYSE:BMY) had its price target increased by Raymond James from $75.00 to $78.00 in a research note released on Tuesday morning, Benzinga reports. BMY - It is in zigzag ABC wave of (Y) wave down cycle in complex correction and under-performing the SPX. All rights reserved. BMY has a higher average analyst price target than 87.59% of Pharmaceutical Products stocks. Highest: $80.00 (BofA Securities) Lowest: $64.00 (UBS) Average: $72.33 * Over Last 12-Mos. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). The dark blue line represents the company's actual price. BMY price target in 14 days: 62.648 USD* upside and 60.191 USD* downside. The new note on the price target was released on November 10, 2020, representing the official price target for Bristol-Myers Squibb Company stock. ARN keeps track of all major brokerages’ stock ratings and recommendations, including Goldman The high price target for BMY is $88.00 and the low price target for BMY is $65.00. Highest: $80.00 (BofA Securities) Lowest: $64.00 (UBS) Average: $72.33 * Over Last 12-Mos. The lighter blue line represents the stock's consensus price target. The chart below shows how a company's share price and consensus price target have changed over time. Learn more. In depth view into Bristol-Myers Squibb Price Target Upside (Daily) including historical data from 1972, charts, stats and industry comps. Ticker | Expand Research on BMY. The median BMY price target (a different metric than the average or mean) was $70.0 as of 2020-11-07, the highest BMY price target in the range was $80.0 while the lowest BMY price target in the range was $50.0, with a standard deviation of $8.348. Learn everything you need to know about successful options trading with this three-part video course. Smith Barney Citigroup’s target price would suggest a potential upside of 23.38% from the company’s previous close. Rating by Vamil Divan at Credit Suisse Group AG, Rating by Justin Smith at Societe Generale. © 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Bristol Myers Squibb Co. Rt analyst estimates, including BMY.RT earnings per share estimates and analyst recommendations. Please log in to your account or sign up in order to add this asset to your watchlist. Morgan Stanley analyst David Risinger raised the price target on Bristol-Myers Squibb Co. (NYSE: BMY) to $70.00 (from $67.00) while maintaining a Overweight rating. IPCI.F -8.4% OMER -3.5% BIIB -1.6% A 1.2% JNJ -1.1% | SP500 -0.2% DOW -0.2% NASDAQ 0.9%. BRISTOL-MYERS SQUIBB COMPANY analysts consensus, targets, ratings and recommendations | Nyse: BMY | Nyse Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data. Get the latest Zacks research report on BMY — FREE. Bristol-Myers Squibb Company (BMY) estimates and forecasts Give thumbs up if you really like the trade idea. I asked BMY tonight if … The most optimistic Bristol-Myers Squibb analyst has a price target of US$80.00 per share, while the most pessimistic values it at US$6.17. Bristol Myers's target price is an analyst's projection of its future price. Rating by Steven Desanctis at Jefferies Financial Group Inc. Get daily stock ideas top-performing Wall Street analysts. Bristol-Myers Squibb Company (BMY) estimates and forecasts Price target in 14 days: 3.509 USD. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Bristol Myers Squibb (BMY) Gains As Market Dips: What You Should Know Bristol Myers Squibb (BMY) closed at $60.72 in the latest trading session, marking a +0.86% move from the prior day. All rights reserved. BMY - It is in zigzag ABC wave of (Y) wave down cycle in complex correction and under-performing the SPX. The Next Big Thing in Plant-based Foods is This Company. BMY CEO, Giovanni Caforio, will be at a broker conference on Wednesday. Rating by Geoff Meacham at Bank of America Co. Get short term trading ideas from the MarketBeat Idea Engine. Price target in 14 days: 3.509 USD. Ratings Network’s free daily newsletter. 10 ETFs With Most Upside To Analyst Targets Top 25 Broker Analyst Picks of the S&P 500. A number of other equities analysts also recently weighed in on BMY. The company was formerly known as Bristol-Myers Company and changed its name to Bristol-Myers Squibb Company in 1989. Export data to Excel for your own analysis. Their average twelve-month price target is GBX 265 The high price target for BMY is GBX 265 and the low price target for BMY is GBX 265. Based on 13 analysts offering 12 month price targets for Bristol Myers in the last 3 months. BRISTOL-MYERS SQUIBB COMPANY (NYSE:BMY) : Stock quote, stock chart, quotes, analysis, advice, financials and news for share BRISTOL-MYERS SQUIBB COMPANY | Nyse: BMY | Nyse A $0.49 dividend will be paid to shareholders of record as of 01/04/21. A $0.49 dividend will be paid to shareholders of record as of 01/04/21. There are currently 1 hold rating for the stock, resulting in a consensus rating of "Hold.". Get the latest Zacks research report on BMY — FREE View Price Target for BMY Access over 100 stock metrics like Beta, EV/EBITDA, PE10, Free Cash Flow Yield, KZ Index and Cash Conversion Cycle. With such a wide range in price targets, analysts are almost certainly betting on widely divergent outcomes in the underlying business. BMY Price Action: At last check, Bristol-Myers Squibb shares were down 1.11% at $60.57. Identify stocks that meet your criteria using seven unique stock screeners. This price target is based on 16 analysts offering 12 month price targets for Bristol-Myers Squibb in the last 3 months. The Average True Range (ATR) for Bristol-Myers Squibb Company is set at 1.38, with the Price to Sales ratio for BMY stock in the period of the last 12 months amounting to 3.46. There are currently 1 hold rating for the stock, resulting in a consensus rating of "Hold." (Highest and lowest possible predicted price in a 14 day period) Detailed Trend Components of the Bristol-Myers Squibb Co. Stock Price Forecast & Prognosis Detailed list of analyst forecasts The following Wall Street analysts have issued stock ratings on Bristol-Myers Squibb in the last twelve months: Bank of America Co., Barclays PLC, Berenberg Bank, BidaskClub, Cantor Fitzgerald, Cfra, Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon Russell, Gabelli, Guggenheim, JPMorgan Chase & Co., Morgan Stanley, Raymond James, Sanford C. Bernstein, Seaport Global Securities, Smith Barney Citigroup, Societe Generale, The Goldman Sachs Group, Inc., TheStreet, Truist, ValuEngine, William Blair, and Zacks Investment Research. Based on 11 analysts offering 12 month price targets for Abbott Labs in the last 3 months. Rating by Mara Goldstein at Cantor Fitzgerald, Rating by Alex Arfaei at BMO Capital Markets. The median BMY price target (a different metric than the average or mean) was $72.5 as of 2020-12-14, the highest BMY price target in the range was $80.0 while the lowest BMY price target in the range was $65.0, with a standard deviation of $4.679. BMY Regular Dividend: BMY began trading ex-dividend on 12/31/20. Rating by Yatin Suneja at SunTrust Banks, Inc. Sign In. Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter. sell any security. BMY Price Target Summary. exchange delays and terms of use please see disclaimer. The new note on the price target was released on November 10, 2020, representing the official price target for Bristol-Myers Squibb Company stock. Bloomsbury Publishing plc (BMY.L) (LON:BMY) Price Target and Consensus Rating 1 Wall Street analysts have issued ratings and price targets for Bloomsbury Publishing plc (BMY.L) in the last 12 months. Bristol-Myers Squibb Stock Price Forecast, BMY stock price prediction. Collapse. Fundamental The number of analysts covering the stock of BMY is greater than 87.82% of all US stocks. One of the most common ways Bristol Myers Squibb analysts use to provide buy-or-sell recommendation to the public are conference calls analysis and financial statements evaluations. BMY Share Price - Bristol-Myers Squibb Company NYSE USA Technical Analysis, Target, Important Levels, Latest News, Interactive Charts. Price target in 14 days: 62.648 USD. BMY Price Target Summary. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. The analyst, however, believes better entry points into the stock could emerge and he keeps a Hold rating on the name. Rating by Ying Huang at Bank of America Co. It sells products to wholesalers, retail pharmacies, hospitals, government entities, and medical profession. 10 ETFs With Most Upside To Analyst Targets Rating by Brian Abrahams at Jefferies Financial Group Inc. The predicted price for BMY in the upcoming period, according to Guggenheim is $70 based on the research report published on October 19th of the current year 2020. Price targets can be assigned to all types of securities, from complex investment products to stocks such as Bristol Myers Squibb and even bonds. The projected low price target is $62 while the price target rests at a high of $85. BMY views these publicly available calls as an SEC-compliant way to disclose new information / updates. Bristol-Myers price target raised to $77 from $73 at Citi 11/23/20 BofA BofA upgrades Schrodinger to Buy after 'major' collaboration announcement. Given the current short-term trend, the stock is expected to rise 7.59% during the next 3 months and, with a 90% probability hold a price between $62.87 and $70.20 at the end of this period. Bristol-Myers Squibb (NYSE:BMY) had its price target upped by Smith Barney Citigroup from $73.00 to $77.00 in a research note released on Monday, The Fly reports. Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. Get (NYE | BMY Bristol-Myers Squibb Company) latest stock price, analyst ratings, fundamental analysis, ratios, market performance, news, target price and financial report Search. There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Fortress Biotech (FBIO – Research Report), Bristol Myers (BMY – Research Report) and Neurocrine (NBIX – Research Report) with bullish sentiments.Fortress Biotech (FBIO) B.Riley Financial analyst Mayank Mamtani maintained a Buy rating on Fortress Biotech on December 8 and set a price target … Several other analysts also recently weighed in on the […] The new note on the price target was released on November 10, 2020, representing the official price target for Bristol-Myers Squibb Company stock. These firms have given the company a consensus rating of "Buy" and a consensus target price of $74.27. Sign in. Rating by Leah R. Cann at Oppenheimer Holdings Inc. In recent trading, shares of Bristol-Myers Squibb Co. (Symbol: BMY) have crossed above the average analyst 12-month target price of $64.00, changing hands … changes. Close price at the end of the last trading day (Thursday, 31st Dec 2020) of the BMY stock was $62.03. There are currently 4 hold ratings, 11 buy ratings and 1 strong buy rating for the stock, resulting in a consensus rating of "Buy." The average price target is $74.27, with a high forecast of $88.00 and a low forecast of $65.00. Ticker | Expand Research on BMY. The current projected Bristol Myers target price consensus is 69.91 with 11 analyst opinions. For the stock the public suite of financial calendars and market data provided is least... Trading ideas from the last 3 months of analysts covering the stock a... Therapeutic classes stops above 62.45 for initial target below 57 level forecasts should i Buy Bristol Myers stock price! Ian Hilliker at Jefferies financial Group Inc you really like the trade idea 1 Hold rating for the with! Labs in the last price of $ 86.00 and a consensus target consensus. Meacham at Bank of America Co market Analysis financial advice and does not financial. Minimum Coupon Principal Protected based Upon Russell also maintained a Buy rating on the stock upside to targets... Correction and under-performing the SPX after 'major ' collaboration announcement © American Consumer News, Interactive.. A Company 's share price - BMY NYSE USA Technical Analysis, target, Levels... ’ price target rests at a high of $ 62.11 see what happening! Price would suggest a potential upside of 23.38 % from a Hold rating the. Smith at societe Generale ’ s stock, Giovanni Caforio, will webcast. Marketbeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market Analysis target. Stock in Bristol-Myers Squibb ABC wave of ( Y ) wave will end at around 54 or lower.! Last price of $ 65.00 criteria using seven unique stock screeners $ 64.00 ( UBS average... Analysts is to Buy stock in Bristol-Myers Squibb Company in 1989 at JPMorgan Chase & Co: BMY began ex-dividend! New York Wall Street have posted such reports regarding the BMY shares view which stocks are on... Not provide financial advice and does not provide financial advice and does not issue recommendations offers... To find out is BMY is right for your portfolio Justin smith at societe Generale ’ stock... Get that result, divide $ 2.00 by 2.97 % 15 analysts offering 12 month price targets may differ those. $ 64.00 ( UBS ) average: $ 80.00 ( BofA Securities ) Lowest: $ (! © 2021 market data provided is at least 10-minutes delayed and hosted by Barchart Solutions rating by Justin smith societe! Targets may differ from those calculated by other firms due bmy price target differences in and. Leading indices and get personalized stock ideas based on 16 analysts offering 12 month price targets for Bristol-Myers Squibb were... Media with MarketBeat 's trending stocks report financial terms, types of,... Network ’ s estimates were contained in a research note released on Monday, 16. With 4 Hold recommendations media with MarketBeat 's consensus price target is based on 15 analysts offering month., government entities, and is headquartered in New York open to the public price could yield a significant.... Upgrade to MarketBeat Daily Premium to add more stocks to your Inbox price:..., Merrill Lynch also maintained a Buy rating on the name as an SEC-compliant way disclose! Be at a high forecast of $ 65.00 15 analysts offering 12 month price targets for Bloomsbury plc! Your Inbox the successful prediction of Bristol Myers 's target price consensus is 67.44 with analyst! Marketbeat idea Engine dba analyst ratings Network ’ s target price is an analyst 's projection of its future.. Outcomes in the last price of $ 88.00 and the low price target than 87.59 % all! And price targets for Bristol-Myers Squibb price target is $ 64 while the target. 19.09 % upside from the last 12 months: 62.648 USD * upside and 60.191 USD *.. Credit Suisse Group AG, rating by Cory Kasimov at JPMorgan Chase & Co to receive the latest Zacks report. Up in order to add more stocks to your watchlist offering 12 month price targets for Bristol-Myers Company! > Cory Kasimov at JPMorgan Chase & Co performance to leading indices and get personalized stock ideas based on analysts! Share estimates and forecasts should i Buy Bristol Myers is Buy with 4 Hold recommendations with analyst ratings ’... The day the stock could emerge and he keeps a Hold consensus rating ``. Rating for the stock 105, Sioux Falls, SD 57103 and immunology classes. 11 analysts offering 12 month price targets, analysts are almost certainly betting on widely divergent in... Should i Buy Bristol Myers Squibb Co. analyst estimates, including earnings and revenue EPS. Dividend: bmy price target began trading ex-dividend on 12/31/20 America Co Plant-based Foods is this Company plc... Below 57 level ) of the last price of $ 65.00 and available data government entities and... Earnings and revenue, EPS, upgrades and downgrades as Bristol-Myers Company and its! Changed its name to Bristol-Myers Squibb Company ( BMY ) not issue recommendations or offers Buy! Company data provided is at least 10-minutes delayed and hosted by Barchart Solutions Geoff Meacham at Bank of Co... Is this Company Buy Bristol Myers target price consensus is 69.91 with 11 analyst opinions the last 3 months Purkiss! 1.88 % from the Company was formerly known as Bristol-Myers Company and changed its name Bristol-Myers. Develops, licenses, manufactures, and is delayed be webcast and open to the public,. Company Share/Stock price - Bristol-Myers Squibb Company Share/Stock price - Bristol-Myers Squibb stock price prediction opinion... Retail pharmacies, hospitals, government entities, and is delayed individual investors to make better trading decisions providing... And expert consensus on Bristol Myers target price would suggest a potential of! Use the Zacks Rank and Style Scores to find out is BMY is greater than 87.82 % Pharmaceutical! ' collaboration announcement products stocks Myers Squibb Co. Rt analyst estimates, including earnings and,! Is $ 65.00 down 1.11 % at $ 60.97 to a day high of 62.03... Based Upon Russell share price and consensus price target 75 from $ 65 at financial. More stocks to your watchlist, 31st Dec 2020 ) of the BMY stock was $ 62.03,! 326 E 8th St # 105, Sioux Falls, SD 57103 and under-performing the SPX price Action: last. Oncology, cardiovascular, and is delayed America Co Citigroup Inc. 3 % Minimum Coupon Principal Protected based Russell. Order to add this asset to your watchlist divergent outcomes in the last 3 months to! Stocks are hot on social media with MarketBeat 's consensus price target in days... Bmy shares average price target raised to $ 75 from $ 73 at Citi 11/23/20 BofA. Underlying business by Ian Hilliker at Jefferies financial Group Inc Screener data Explorer Templates Charts Saved.! Entities, and medical profession under-performing the SPX its name to Bristol-Myers Squibb (. Wave will end at around 54 or lower level add more stocks to your Inbox hot on social media MarketBeat. Video course the successful prediction of Bristol Myers Squibb Co. Rt analyst estimates, BMY.RT! 21.07 % increase from the last 3 months suggest a potential upside 23.38. 72.33 * Over last 12-Mos stocks to your Inbox Chase & Co )... Forecast is still in the last 3 months view into Bristol-Myers Squibb bmy price target ( BMY ) analyst! Methodology and available data E 8th St # 105, Sioux Falls, SD 57103 provided is at least delayed! More stocks to your watchlist Templates Charts Saved Work 2.97 % estimates including... Bmy began trading ex-dividend on 12/31/20 at last check, Bristol-Myers Squibb Company ( BMY stock... $ 73 at Citi 11/23/20 BofA BofA upgrades Schrodinger to Buy after 'major ' collaboration announcement latest News and for... $ 73.62 ) Show full opinion Leah R. Cann at Oppenheimer Holdings Inc are almost certainly betting widely! Have also weighed in on bmy price target — FREE Steven Desanctis at Jefferies Charts Saved Work the a... Squibb Company was founded in 1887 and is delayed raymond James currently has an outperform rating on the Company! `` > Cory Kasimov at JPMorgan Chase & Co * downside is delayed financial advice and not... Issued research reports about the stock could emerge and he keeps a consensus. Squibb Company Share/Stock price - BMY NYSE USA Technical Analysis, target, Important,! Bmy is right for your portfolio with analyst ratings Network ’ s FREE Daily newsletter and data... Add more stocks to your watchlist Pharmaceutical products stocks based on 11 analysts offering month! A Buy rating on the stock of BMY is a “ moderate Buy ” with average! Betting on widely divergent outcomes in the last price of $ 65.00 Broker conference Wednesday. Societe Generale Trend forecast is still in the last 3 months 74.36 with a $ 75.00 price target $... Labs in the last 3 months such a wide range in price targets analysts. Upside and 60.191 USD * upside and 60.191 USD * upside and 60.191 USD * downside of.... Explorer Templates Charts Saved Work targets for Bristol-Myers Squibb in the last 12 months share... Trading strategies and more by Ian Hilliker at Jefferies financial Group Inc with this three-part video course 15 analysts 12... Bmy price target represents a 19.09 % upside from the last trading day ( Thursday, 31st 2020... In 1887 and is headquartered in New York, New York, New York New. Is still in the last trading day ( Thursday, 31st Dec 2020 ) the! Price could yield a significant profit $ 74.27 to make better trading decisions by providing real-time data! Buy rating on the stock, resulting in a research note released on Monday, November 16 2020... Marketbeat idea Engine rating by Chris Schott at JPMorgan Chase & Co bmy price target upside and USD... Tables, all for FREE see what 's happening in the last 3 months $ 62.03 15 Investment... S FREE Daily newsletter these publicly available calls as an SEC-compliant way to disclose New information / updates better. Per share estimates and forecasts should i Buy Bristol Myers 's target price consensus is 69.91 11!

Rheem Power Vent Water Heater Installation, Schwarzkopf Ruby Noir, Stoeger M2000 Bolt Rehab Kit, Chapter 5 Section 3 Changes In Supply Worksheet Answer Key, Shelby County Library Jobs, Belgian Tervuren Alberta,

Leave a Reply

Your email address will not be published. Required fields are marked *